Coronary arteries, myocardial infarction, and history [7]

New England Journal of Medicine

Volumn 366, Issue 13, 2012, Pages 1258-1260

  Laing, B Yoshio ^a   Katz, Mitchell H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; SATURATED FATTY ACID;

BARE METAL STENT; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DRUG ELUTING STENT; FAT INTAKE; HEART DEATH; HEART INFARCTION; HISTORY OF MEDICINE; HUMAN; LETTER; MEDICAL PROCEDURES; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; RISK REDUCTION; SMOKING; SURVIVAL TIME; THERAPY EFFECT; TREND STUDY;

EID: 84859097232     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1201171     Document Type: Letter

References (4)

1. Nabel E, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2011;366:54-63.
2. Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst Rev 2010;5:CD004587.
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. [Erratum, BMJ 2002;324:141.]
4. Achievements inpublic health, 1900-1999: decline in deaths from heart disease and stroke - United States, 1900-1999. MMWR Morb Mortal Wkly Rep 1999;48:649-56 (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4830a1.htm).